Syquant Capital Sas’s Aimmune Therapeutics Inc Position
Does Syquant Capital Sas own Aimmune Therapeutics Inc (AIMT)? Not currently — the last reported position was 125.5K shares worth $4M in Q3 2020; the fund’s latest 13F (Q2 2026) no longer reports it.
Position Value
$4M
Q3 2020
Shares
125.5K
% of Portfolio
+2.20%
Quarters Held
1
position exited
Position History AIMT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2020 | 125.5K | $4M | +2.20% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Syquant Capital Sas’s full portfolio or all institutional holders of AIMT.